News Center

By Jim Roach, M.D., Senior Vice President and Global Head, Rare Diseases Therapeutic Area There…

By David Loew, CEO The annual European Society for Medical Oncology (ESMO) congress is…

We are pleased to announce the appointment of Bartek Bednarz, Executive Vice President Global Product…

We are pleased to announce a resilient financial performance for H1 2020, despite the…

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the…

We are delighted to welcome David Loew as the new CEO of Ipsen. A seasoned…

In 2019, for the first time, Ipsen committed to introduce Environmental, Social and Governance (ESG)…

Last summer, Ipsen, headquartered in Boulogne, France and Debiopharm, headquartered in Lausanne, Switzerland announced…

We have just completed the first-ever virtual ASCO Annual Meeting.  It is amazing that ASCO…

World Kidney Cancer Day is taking place on 18 June 2020, and this year we…

Yesterday, Richard Paulson, CEO of North America, joined other biotech and industry leaders by sharing…

Jim Roach MD, FACP, FCCP, SVP and Global Head, Rare Diseases Therapeutic Area, Ipsen Rare…